Figure 5

Overall survival rates of GC patients based on Fusobacterium spp. and F. nucleatum status. (A) Overall survival rates of GC patients with positive and negative Fusobacterium spp. status (p = 0.285). (B) Overall survival rates of GC patients with positive and negative F. nucleatum status (p = 0.129). (C) Overall survival rates of GC patients with Lauren’s diffuse type with positive and negative Fusobacterium spp. status (p = 0.536). (D) Overall survival rates of GC patients with Lauren’s intestinal and mixed types with positive and negative Fusobacterium spp. status (p = 0.798). (E) Overall survival rates of GC patients with Lauren’s diffuse type gastric cancer with positive and negative F. nucleatum status (p = 0.0009). (F) Overall survival rates of GC patients with Lauren’s intestinal and mixed types with positive and negative F. nucleatum status (p = 0.643). Log-rank (Mantel–Cox) test was used for survival data.